Some have relabeled it as Pentadecapeptide Aringate or PDA (modifying the acetate to an arginate) and therefore are prescribing it for subcutaneous administration this way, though the confusion about its status has led to a lively oral capsule market for BPC in what seems to be a grey place of https://soichiroa197cmw7.eedblog.com/profile